Intracytoplasmic Sperm Injection May Not Improve Clinical Outcomes Despite Its Positive Effect on Embryo Results: A Retrospective Analysis of 1130 Half-ICSI Treatments.

Peng, Nan; Ma, Shuiying; Li, Cheng; Liu, Hui; Zhao, Haibin; Li, Lian-Jie; Li, Qing; Li, Mei

Peng, Nan; Ma, Shuiying; Li, Cheng; Liu, Hui; Zhao, Haibin; Li, Lian-Jie; Li, Qing; Li, Mei.

Afiliação

Peng N; Center for Reproductive Medicine, Cheeloo College of Medicine, Shandong University, Jinan, China.
Ma S; Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, China.
Li C; Shandong Key Laboratory of Reproductive Medicine, Jinan, China.
Liu H; Shandong Provincial Clinical Research Center for Reproductive Health, Jinan, China.
Zhao H; National Research Center for Assisted Reproductive Technology and Reproductive Genetics, Shandong University, Jinan, China.
Li LJ; Center for Reproductive Medicine, Cheeloo College of Medicine, Shandong University, Jinan, China.
Li Q; Key Laboratory of Reproductive Endocrinology of Ministry of Education, Shandong University, Jinan, China.
Li M; Shandong Key Laboratory of Reproductive Medicine, Jinan, China.

Front Endocrinol (Lausanne) ; 13: 877471, 2022.

Article em En | MEDLINE | ID: mdl-35784567

Assuntos

Infertilidade; Injeções de Esperma Intracitoplásmicas; Embrião de Mamíferos; Feminino; Humanos; Masculino; Gravidez; Estudos Retrospectivos; Sêmen

Palavras-chave

2PN; clinical outcome; half-ICSI; high-quality embryo; live birth; oocyte utilization rate

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Injeções de Esperma Intracitoplásmicas / Infertilidade Tipo de estudo: Observational_studies Limite: Female / Humans / Male / Pregnancy Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google